机译:华法林剂量与参与其作用和代谢的基因的关联
Department of Medical Sciences Clinical Pharmacology University Hospital 751 85 Uppsala Sweden;
The Wellcome Trust Sanger Institute Wellcome Trust Genome Campus Hinxton Cambridgeshire CB10 1SA UK;
UCR—Uppsala Clinical Research Center Uppsala Science Park 751 83 Uppsala Sweden;
The Wellcome Trust Sanger Institute Wellcome Trust Genome Campus Hinxton Cambridgeshire CB10 1SA UK;
The Wellcome Trust Sanger Institute Wellcome Trust Genome Campus Hinxton Cambridgeshire CB10 1SA UK;
Department of Genetics and Pathology Medical Genetics Rudbeck Laboratory 751 85 Uppsala Sweden;
The Wellcome Trust Sanger Institute Wellcome Trust Genome Campus Hinxton Cambridgeshire CB10 1SA UK;
The Wellcome Trust Sanger Institute Wellcome Trust Genome Campus Hinxton Cambridgeshire CB10 1SA UK;
The Wellcome Trust Sanger Institute Wellcome Trust Genome Campus Hinxton Cambridgeshire CB10 1SA UK;
机译:华法林剂量与参与其作用和代谢的基因的关联。
机译:评估与华法林代谢和作用机理有关的九种遗传变异用于稳定剂量预测
机译:对与华法林的代谢和作用机制有关的九种遗传变异进行评估,并将其应用于稳定剂量预测。
机译:锌的来源和水平影响参与肉类脂质代谢的基因的表达
机译:新型基于遗传的华法林剂量诺模图的开发和验证。
机译:华法林剂量与参与其作用和代谢的基因的关联
机译:华法林剂量与参与其作用和代谢的基因的关联